Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|April 12, 2025
Inflammatory Pseudotumor of the Anal Canal Mimicking Colorectal Cancer: Case Report and Hints to Improve a Patient's Fitness for Treatment and PreventionVito Rodolico, Paola Di Carlo, Girolamo Geraci, et al.
Anticancer Research|May 27, 2004
Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosisMaria Meli, Manlio Tolomeo, Natale D'Alessandro, et al.
Chemmedchem|June 29, 2017
Effects of Pimozide Derivatives on pSTAT5 in K562 CellsRiccardo Rondanin, Daniele Simoni, Martina Maccesi, et al.
Oncology Reports|December 5, 2006
The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cellsMaria Meli, Manlio Tolomeo, Mario Grifantini, et al.
Anti-Cancer Drugs|February 2, 2013
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cellsStefania Grimaudo, Maria Meli, Antonietta Di Cristina, et al.
International Journal of Oncology|February 15, 2011
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cellsMaria Meli, Manlio Tolomeo, Mario Grifantini, et al.
Bioorganic & Medicinal Chemistry Letters|August 19, 2014
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivativesRiccardo Rondanin, Daniele Simoni, Romeo Romagnoli, et al.
Cancer Letters|April 1, 2008
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cellsManlio Tolomeo, Stefania Grimaudo, Antonietta Di Cristina, et al.
European Journal of Medicinal Chemistry|December 3, 2015
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylationRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
European Journal of Medicinal Chemistry|February 26, 2014
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitorsRiccardo Baruchello, Daniele Simoni, Paolo Marchetti, et al.
Pageof 3